-
04/18/25 Health Advisory: Stay alert for measles cases
Summary: Recognize measles and notify the Health Department. Consider measles as a diagnosis in anyone who: If you suspect measles, call the Health Department before the patient leaves the clinic using . Background There is a large, ongoing measles outbreak in Texas. Several other states have reported smaller outbreaks of measles. Here in Washington, 4 cases have…
-
03/27/2024 Health Advisory: Measles Increasing in Washington, the Nation, and the World
Summary Background Measles is a highly contagious viral illness that can lead to severe health complications, like pneumonia, encephalitis, and death, especially in unvaccinated people. Measles outbreaks have occurred in Washington, the United States, and around the world in 2024. Outbreaks often start when an unvaccinated or under-vaccinated person is exposed during international travel and…
-
01/19/24 Health Advisory: Measles Outbreak in Southwest Washington
An active measles outbreak investigation is underway in Clark and Wahkiakum Counties. As of Jan. 10, 2024, investigators have identified 3 lab-confirmed and 3 epidemiologically linked measles cases in unvaccinated adults. Symptoms began in mid-to-late December. All report isolating at home during their contagious period. Investigators have not identified any public exposure locations. Healthcare providers…
-
12/15/23 Health Advisory: Test for tuberculosis people who were incarcerated
A large outbreak of tuberculosis (TB) in the state prison system may affect more than 800 people who were incarcerated. Requested actions Ask patients about risk factors for TB exposure: Test people with risk factors unless they have a known history of TB infection or TB disease. Evaluate people who test positive to rule out…
-
09/20/23 Health Advisory: New COVID-19 Vaccines Authorized, Previous Bivalent COVID-19 Vaccines Deauthorized
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, News and Alerts, Provider ResourcesOn Sept. 11, 2023, U.S. Food and Drug Administration (FDA) authorized for emergency use new, updated (2023–2024) COVID-19 vaccines from Moderna and Pfizer. FDA deauthorized previous bivalent COVID-19 vaccines. On Sept. 11, 2023, FDA deauthorized previous bivalent COVID-19 vaccines from Moderna and Pfizer. CDC recommends new, updated (2023–2024) COVID-19 vaccines. CDC’s new, updated (2023–2014) COVID-19…
-
04/24/23 Health Advisory: Bivalent COVID-19 Vaccine Use Expanded, Monovalent No Longer Authorized
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, Immunizations, News and Alerts, Notifiable Conditions, Provider ResourcesRequested actions Monovalent Moderna and Pfizer COVID-19 vaccines are no longer authorized for use in the United States. Read below for how to discard and report as waste. Use the new simplified schedule to administer COVID-19 vaccine. People who are 65 years or older or have immune compromise can now get a second bivalent booster…
-
03/14/23 Health Advisory: Extensively Drug-Resistant Shigellosis
Advisory or Update, Communicable Disease and Immunization Update, Health Advisory, Infection Control, Notifiable Conditions, Provider Resources, TravelRequested actions Background Shigellosis is an acute enteric infection. It is an important cause of domestically acquired and travel-associated bacterial diarrhea in the United States. A low infectious dose makes Shigella bacteria easily transmitted from person to person. Consider shigellosis in the differential diagnosis of acute diarrhea, especially in people who: Shigellosis can be a mild,…
-
02/03/23 Health Advisory: Multistate Cluster of Antibiotic Resistant Bacteria Associated with Artificial Tears
Actions requested Background Washington State Department of Health (DOH) and Centers for Disease Control and Prevention (CDC) are investigating a cluster of antibiotic-resistant infections that may be linked to artificial tears. The most frequently reported brand was EzriCare Artificial Tears, a preservative-free product dispensed in muti-dose bottles. These over-the-counter eye drops are sold widely in…
-
11/23/22 Health Advisory: Pediatric Respiratory Illness Increasing
Advisory or Update, Communicable Disease and Immunization Update, Health Advisory, Influenza, Influenza UpdateHealth Advisory: Pediatric respiratory illness increasing in Western Washington Published Nov. 23, 2022. Situation update Information for healthcare providers Nurse advice lines Apple Health Plans Amerigroup (AMG) (866) 864-2544 Community Health Plan (CHPW) (866) 418-2920 Coordinated Care (CCW) (877) 644-4613 Molina Healthcare (MHC) (888) 275-8750 United Healthcare (UHC) (877) 543-3409 Premera Blue Cross and LifeWise…
-
11/08/22 Health Advisory: Increased Respiratory Virus Activity
Advisory or Update, Health Advisory, Immunizations, Infection Control, News and Alerts, Provider Resources, SchoolsMultiple viruses are causing increased respiratory illness, especially among children, straining healthcare systems. Transmission of respiratory illnesses is increased in our communities. Schools report much higher absenteeism than normal for this time of year. Our hospital emergency departments are seeing many patients. This increase in illness early in respiratory illness season highlights the importance of…
-
10/03/22 Health Advisory: Severe cases of monkeypox among people with immune compromise
Advisory or Update, Communicable Disease and Immunization Update, Health Advisory, monkeypox, Notifiable Conditions, Provider ResourcesSince May 2022, the United States has seen more than 25,000 cases of monkeypox virus (MPV). Most cases are mild to moderate, but some people are at higher risk of severe illness: Under 8 years old. Immune compromise. Atopic dermatitis or eczema. Pregnant. Unsuppressed or uncontrolled human immunodeficiency virus (HIV). Of those currently diagnosed with MPV…
-
09/09/02 Health Advisory: COVID-19 and Monkeypox Update for Providers
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, Immunizations, monkeypox, Notifiable Conditions, Provider ResourcesCOVID-19 On Sept. 1, 2022, Centers for Disease Control and Prevention (CDC) endorsed Advisory Committee on Immunization Practices’ (ACIP’s) recommendation of Moderna and Pfizer COVID-19 vaccine bivalent booster doses. Bivalent booster doses enhance immunity against the ancestral coronavirus strain and protect against newer Omicron variants that account for most current cases. Bivalent booster doses provide optimal protection and…
-
09/02/22 Health Advisory: Bivalent Vaccine Booster for COVID-19
Advisory or Update, COVID-19, Health Advisory, Immunizations, Notifiable Conditions, Provider ResourcesRequested actions Be aware: Moderna and Pfizer created bivalent formulations of their mRNA COVID-19 vaccines. The bivalent vaccines target the original strain of SARS-CoV-2 and Omicron subvariants BA.4 and BA.5. United States Food and Drug Administration (FDA) granted emergency use authorization (EUA) to the bivalent vaccines for use as a single booster dose. People can get…